| Literature DB >> 30392983 |
Karin K M Chia1, Logan Kanagaratnam2, Kevin Hellestrand3, Peter Kowey4, David Whalley3.
Abstract
While implantable cardioverter defibrillators decrease mortality in high risk groups of patients who have ventricular arrhythmias, antiarrhythmic drugs are still required to reduce the burden of both benign and life-threatening arrhythmias. This review will address the available medical therapy for ventricular arrhythmias in Australia and their use in different clinical situations.Entities:
Keywords: Pharmacological therapy; Ventricular fibrillation; Ventricular tachycardia
Mesh：
Substances：
Year: 2018 PMID： 30392983 DOI： 10.1016/j.hlc.2018.10.002
Source DB: PubMed Journal: Heart Lung Circ ISSN： 1443-9506 Impact factor: 2.975